Influence of Apoptosis and Cell Cycle Regulator Proteins on Chemotherapy Response and Survival in Stage IIIA/IIIB NSCLC Patients José L. Morero, MD, Claudia Poleri, MD, Claudio Martín, MD, Maximiliano Van Kooten, MD, Reynaldo Chacón, MD, Moisés Rosenberg, MD Journal of Thoracic Oncology Volume 2, Issue 4, Pages 293-298 (April 2007) DOI: 10.1097/01.JTO.0000263711.54073.fa Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 1 Time to progression with respect to Ki67 pre-QT expression (high, 7/32 patients; low/moderate, 25/32 patients). Journal of Thoracic Oncology 2007 2, 293-298DOI: (10.1097/01.JTO.0000263711.54073.fa) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 2 Time to progression with respect to p21 pre-chemo expression (high, 13/33 patients; low, 20/33). Journal of Thoracic Oncology 2007 2, 293-298DOI: (10.1097/01.JTO.0000263711.54073.fa) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions